Search clinical trials for: Plavix (Clopidogrel)

Total 1297 results

University of Pecs
Hungarian Academy of Sciences; KRKA

Completed

Comparison of Generic and Original Formulation of Clopidogrel (DOSER-GENERIC)

Coronary Heart Disease | Percutaneous Coronary Intervention
Eli Lilly and Company
Daiichi Sankyo, Inc.

Completed

Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event (SWAP)

Acute Coronary Syndrome | Coronary Arteriosclerosis

United States
Khon Kaen University

Completed

Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products

Pharmacodynamics

Thailand
Centre Hospitalier de PAU

Terminated

Anticoagulant Treatments and Percutaneous Coronary Angioplasty (TACA)

Coronary Artery Disease

France
Stiftung Institut fuer Herzinfarktforschung
Bristol-Myers Squibb; Sanofi

Completed

CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction

Myocardial Infarction

Germany, Austria
Hospital Central San Luis Potosi, Mexico

Unknown

Patent Versus Generic Clopidogrel in Acute Coronary Syndrome

Acute Coronary Syndrome
Lady Reading Hospital, Pakistan
Pakistan Chest Society, Pakistan

Recruiting

Clopidogrel for the Prevention of Exacerbations in Severe COPD (CLOPEX)

COPD | COPD Exacerbation Acute

Pakistan
Deutsches Herzzentrum Muenchen

Terminated

Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation (ISAR-CAUTION)

Coronary Artery Disease

Germany
University of North Carolina, Chapel Hill

Completed

Clopidogrel Pharmacogenomics Project

Disease Susceptibility

United States
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

Coronary Artery Disease

Korea, Republic of
Ospedale San Donato

Completed

Safety and Efficacy of Three Different Loading Doses of Clopidogrel, in Patients With Acute Myocardial Infarction (Load & Go)

Acute Myocardial Infarction

Italy
Ajou University School of Medicine
Dong-A Pharmaceutical

Completed

Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)

Acute Coronary Syndrome

Korea, Republic of
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Migraine Prophylaxis With Clopidogrel Trial

Migraine

China
Hospital Universitario Dr. Jose E. Gonzalez

Terminated

Comparative Bioavailability Study of Two Oral Formulations of Clopidogrel

Comparative Bioavailability of Clopidogrel Tablets

Mexico
Chinese University of Hong Kong

Completed

Uninterrupted Clopidogrel Therapy Before Elective Colonoscopy Will Increase the Risk of Post-polypectomy Bleeding

Gastrointestinal Bleeding

China
University of Florida
Scott R. MacKenzie Foundation

Completed

Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus

Coronary Artery Disease (CAD) | Type 2 Diabetes Mellitus (T2DM) | Chronic Kidney Disease (CKD)

United States
Portola Pharmaceuticals

Completed

A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI (INNOVATE-PCI)

Percutaneous Coronary Intervention

United States, Austria, Canada, Germany, Poland
Charles University, Czech Republic

Temporarily not available

Clopidogrel Resistance and the Possibility of Its Affection

Coronary Artery Disease

Czechia
Jiangsu vcare pharmaceutical technology co., LTD

Completed

PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers

Acute Coronary Syndrome

United States, China
Lawson Health Research Institute

Completed

Effect of Ticagrelor on Endothelial Function

Coronary Artery Disease | Endothelial Function

Canada
Kyunghee University Medical Center
Kyunghee University

Completed

ONSET and OFFSET of Ticagrelor in ESRD

Chronic Kidney Disease

Korea, Republic of
University Medical Centre Ljubljana

Completed

Antiplatelet Therapy After Cardiac Arrest

Cardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)

Slovenia
Sanofi
Bristol-Myers Squibb

Completed

Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation (CLARINET)

Heart Defects, Congenital

France, Canada, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Sweden, India, Malaysia, Singapore, Taiwan, Belgium, Mexico, Argentina, Denmark, Egypt, Finland, Hungary, Israel, Norway, Korea, Republic of, Hong Kong and more
AstraZeneca

Terminated

Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin. (NSTE-ACS)

Non-ST Elevation Acute Coronary Syndrome

United States
Sanofi
Bristol-Myers Squibb

Completed

Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function

Peripheral Arterial Disease

Hungary
Beth Israel Deaconess Medical Center

Terminated

Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.

Myocardial Ischemia | Coronary Artery Disease | Bleeding

United States
Ruhr University of Bochum

Completed

Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan) (BOCLAplan)

Coronary Artery Disease

Germany
Rabin Medical Center
Rambam Health Care Campus; Meir Medical Center; Sheba Medical Center; Tel Aviv...

Unknown

Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel (MATTIS-D)

Coronary Disease | Diabetes Mellitus

Israel
Seoul National University Hospital
CKD Pharmaceutical Limited

Completed

Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

Coronary Heart Disease
HK inno.N Corporation

Completed

Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers

Healthy

Korea, Republic of
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Unknown

Role of Immune Responses After Acute Myocardial Infarction (BATTLE-AMI)

Myocardial Fibrosis

Brazil
Lene Holmvang

Completed

Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI (TAILOR)

Coronary Artery Disease | Percutaneous Coronary Intervention | Acute Coronary Syndromes

Denmark
Takeda

Completed

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Healthy

United States
Centre hospitalier de l'Université de Montréal...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Withdrawn

Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients (PANDDA)

Diabetes

Canada
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg

Healthy

United States
Creighton University

Withdrawn

Clinical Management of Antiplatelet Drug Resistance in Patients With Drug Eluting Coronary Stents

Coronary Artery Disease

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg

Healthy

United States
Joint Stock Company "Farmak"

Completed

Fasted Bioequivalence Study of Clopidogrel Film-coated Tablets, 75 mg in 48 Healthy, Adult Male and Female Subjects.

Pharmacokinetics

Ukraine
Ain Shams Maternity Hospital

Unknown

Comparison Between Effect of Enoxaparin and Clopidogrel on Improving Pregnancy Rate in ICSI

Female , Infertility

Egypt
AstraZeneca

Withdrawn

Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients (PAD)

Intermittent Claudication | Peripheral Artery Disease | Vascular Disease | Arterial Occlusion Disease | Ankle Brachial Index (0.9 or Less)
Laval University
Bristol-Myers Squibb; Sanofi

Completed

Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects (CANOA)

Migraine

Canada
Dong-A University

Completed

Clopidogrel And Ticagrelor in Healthy Subjects

Pharmacodynamics

Korea, Republic of
University of Maryland, Baltimore
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

Clopidogrel Pharmacogenetics (PGX) Bench to Bedside (PGXB2B)

Metabolism of Clopidogrel

United States
University of Maryland, Baltimore
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study (PAPI-2)

Cardiovascular Diseases | Acute Coronary Syndrome

United States
Sanofi
Bristol-Myers Squibb

Completed

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

Atrial Fibrillation | Vascular Risk

United States, France, Canada, Brazil, Poland, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Argentina, Denmark, Finland, Hungary, Norway, United... and more
Ronald Hoffman
National Cancer Institute (NCI); Myeloproliferative Disorders-Research Consortium

Withdrawn

Clopidogrel and Aspirin for the Treatment of Polycythemia Vera (ISCLAP)

Polycythemia Vera
Inje University

Completed

The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers

Interaction
Scripps Health
National Center for Research Resources (NCRR)

Completed

Pilot Study on the Effect of High Clopidogrel Maintenance Dosing (PREDICT)

Coronary Artery Disease

United States
Ottawa Heart Institute Research Corporation

Completed

Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not?

Acute Coronary Syndrome

Canada
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions

Fasting

Canada

Search clinical trials for: Plavix (Clopidogrel)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations